Eidenberger, Anna
Birner, Klaudia
Frank-Publig, Sophie
Schrittwieser, Johannes
Tratnig-Frankl, Merle
Gumpinger, Markus
Schmidt-Erfurth, Ursula
Article History
Received: 19 August 2025
Accepted: 29 January 2026
First Online: 4 February 2026
Declarations
:
: AE, KB, SFP, JS, MTF, MG: none USE: AbbVie (C), ADARx (C), Alcon (C), Alkeus (C), Allergan (C), Annexon (C), Apellis (C, F), Astellas (C), Aviceda (C), Bayer (C), Boehringer Ingelheim (C), Complement Therapeutics (C), EcoR1 (C), Galimedix (C), Genentech (F) Heidelberg Engineering (F), Janssen (C), Kodiak (C, F), Medscape (C), ONL (C), RetInSight (F), Roche (C, F), Topcon (C).